Durable Remission Achieved from Bcma-Directed CAR-T Therapy Against Relapsed or Refractory Multiple Myeloma

doi:10.1182/blood-2018-99-112786

科研成果详情

题名	Durable Remission Achieved from Bcma-Directed CAR-T Therapy Against Relapsed or Refractory Multiple Myeloma
作者	Liu, Yarong 1; Chen, Zhi 2; Fang, Hongliang 1; Wei, Runhong 2; Yu, Kang3; Jiang, Songfu3; Fu, Weijun 4; Jiang, Hua 5; Du, Juan 4; He, Feng 1; Xie, Ronglin 1; Chen, Jing 1; Wei, Baofeng 1; Tao, Jin 1; Wang, Pin 6
会议录名称	BLOOD 影响因子和分区
语种	英语
原始文献类型	Meeting Abstract
会议名称	60th Annual Meeting of the American-Society-of-Hematology (ASH)
会议日期	DEC 01-04, 2018
会议地点	San Diego, CA
出版地	WASHINGTON
出版者	AMER SOC HEMATOLOGY
ISSN	0006-4971
EISSN	1528-0020
卷号	132
DOI	10.1182/blood-2018-99-112786
页数	2
WOS类目	Hematology
WOS研究方向	Hematology
WOS记录号	WOS:000454837602332
收录类别	SCIE ; CPCI ; CPCI-S
发表日期	2018-11-29
自定义期刊分类	T2(B)类
引用统计	被引频次：26[WOS] [WOS记录] [WOS相关记录]
文献类型	会议论文
条目标识符	https://kms.wmu.edu.cn/handle/3ETUA0LF/21484
专题	附属第一医院_血液内科
作者单位	1.HRAIN Biotechnol, Shanghai, Peoples R China; 2.Henan Univ Tradit Chinese Med, Dept Hematol, Affiliated Hosp 2, Zhengzhou, Henan, Peoples R China; 3.Wenzhou Med Univ, Dept Hematol, Affiliated Hosp 1, Wenzhou, Peoples R China; 4.Shanghai Chang Zheng Hosp, Dept Hematol, Myeloma & Lymphoma Ctr, Shanghai, Peoples R China; 5.Shanghai Changzheng Hosp, Dept Hematol, Myeloma & Lymphoma Ctr, Shanghai, Peoples R China; 6.Univ Southern Calif, Chem & Biomed Engn, Los Angeles, CA USA
推荐引用方式 GB/T 7714	Liu, Yarong,Chen, Zhi,Fang, Hongliang,et al. Durable Remission Achieved from Bcma-Directed CAR-T Therapy Against Relapsed or Refractory Multiple Myeloma[C]. WASHINGTON:AMER SOC HEMATOLOGY,2018.